Trials / Completed
CompletedNCT05966688
A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants
A Phase 1 Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Spero Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to evaluate the pharmacokinetics (PK) of SPR720, azithromycin, and ethambutol, administered separately and co-administered, in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPR720 | Multiple oral doses of SPR720 capsules. |
| DRUG | Azithromycin | Multiple oral doses of azithromycin. |
| DRUG | Ethambutol | Multiple oral doses of ethambutol. |
Timeline
- Start date
- 2023-08-04
- Primary completion
- 2024-01-30
- Completion
- 2024-02-04
- First posted
- 2023-08-01
- Last updated
- 2024-03-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05966688. Inclusion in this directory is not an endorsement.